Newsroom
The latest news and updates on Sooma tDCS™, neurostimulation treatment, and what’s happening at Sooma Medical.
Sooma Secures €5M Funding for At-home Brain Stimulation Therapies
Read more
Dr. Daniel Blumberger Joins Sooma’s Science Advisory Board
Read more
Reflecting on a Year of Innovation and Achievement: Sooma in 2023
Read more
Sooma launches system for remote clinician-monitored brain stimulation
Read more
Sooma becomes the first tDCS device manufacturer to receive European MDR certification
Read more
Open-Label Study Highlights Efficacy of Sooma Depression Therapy for MDD Treatment
Read more
Sooma Receives Intention to Grant Patent from EPO for Its Innovative Electrode Placement System, Reinforcing Patent Portfolio
Read more
FDA Breakthrough Device Designation granted to Sooma for Its Innovative At-Home Depression Treatment Device
Read more
New European Regulation reclassifies brain stimulation equipment without an intended medical purpose as class III
Read more
Sooma’s latest study provides the largest dataset to date on the effects of tDCS for treating MDD in real-world clinical practice
Read more